Search Results 1451-1460 of 18393 for Immunode

  1. Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

    Seroreactivity for human immunodeficiency virus (HIV), human T-lymphotropic virus (HTLV) I or II, hepatitis B virus (HBV), hepatitis C virus (HCV); Other ...

  2. A Study to Evaluate the Combination of Binimetinib and Palbociclib in Treating Patients with KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer - Mayo Clinic

    Known positive serology for HIV (human immunodeficiency virus), active hepatitis B, and/or active hepatitis C infection. Patients who have neuromuscular ...

  3. Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA) - Mayo Clinic

    Known positive human immunodeficiency virus (HIV) 14. Received a live virus vaccine within 1 month of the baseline visit 15. Current or prior positive ...

  4. A Study of STX-0712 in Patients with Advanced Hematologic Malignancies - Mayo Clinic

    Known human immunodeficiency virus (HIV); Active or chronic hepatitis B or hepatitis C infection; Known hypersensitivity to any of the components of STX-0712 ...

  5. Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients (IMAGINE) - Mayo Clinic

    History of human immunodeficiency virus (HIV) infection or positive for HIV. 7. Seropositive for hepatitis B surface antigen (HBsAg) 8. Hepatitis C virus ...

  6. Itchy skin (pruritus) - Symptoms and causes - Mayo Clinic

    Eczema, atopic dermatitis, and noninfectious immunodeficiency disorders. In: Andrews' Diseases of the Skin: Clinical Dermatology. 13th ed. Elsevier; 2020 ...

  7. Immune Aging - Mayo Clinic

    About this study. The objective of this study is to identify immune defects that compromise the immune response with age. As humans age, vaccinations become ...

  8. Study Of Chemotherapy Plus Ipatasertib For People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial - Mayo Clinic

    - Participants with known human immunodeficiency virus (HIV)-infection must be receiving anti-retroviral therapy and have an undetectable viral load test on ...

  9. Study to Evaluate CCS1477 in Haematological Malignancies - Mayo Clinic

    ... immunodeficiency virus (HIV)*), which in the investigator's opinion makes it undesirable for the patient to participate in the study or which would ...

  10. Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations - Mayo Clinic

    * Active hepatitis B or C infection and/or known human immunodeficiency virus (HIV) carrier. * Poorly controlled gastrointestinal disorders. Note: Other ...